Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Department of Chemistry and Biochemistry, California State University, Los Angeles, Los Angeles, CA, USA.
Toxicol Lett. 2022 Sep 1;368:9-23. doi: 10.1016/j.toxlet.2022.07.009. Epub 2022 Jul 25.
Antifreeze proteins (AFPs), found in many cold-adapted organisms, can protect them from cold and freezing damages and have thus been considered as additional protectants in current cold tissue preservation solutions that generally include electrolytes, osmotic agents, colloids and antioxidants, to reduce the loss of tissue viability associated with cold-preservation. Due to the lack of toxicity profile studies on AFPs, their inclusion in cold preservation solutions has been a trial-and-error process limiting the development of AFPs' application in cold preservation. To assess the feasibility of translating the technology of AFPs for mammalian cell cold or cryopreservation, we determined the toxicity profile of two highly active beetle AFPs, DAFP1 and TmAFP, from Dendroides canadensis and Tenebrio molitor in this study. Toxicity was examined on a panel of representative mammalian cell lines including testicular spermatogonial stem cells and Leydig cells, macrophages, and hepatocytes. Treatments with DAFP1 and TmAFP at up to 500 μg/mL for 48 and 72 h were safe in three of the cell lines, except for a 20% decrease in spermatogonia treated with TmAFP. However, both AFPs at 500 μg/mL or below reduced hepatocyte viability by 20-40% at 48 and 72 h. At 1000 μg/mL, DAFP1 and TmAFP reduced viability in most cell lines. While spermatogonia and Leydig cell functions were not affected by 1000 μg/mL DAFP1, this treatment induced inflammatory responses in macrophages. Adding 1000 μg/mL DAFP1 to rat kidneys stored at 4 °C for 48 h protected the tissues from cold-related damage, based on tissue morphology and gene and protein expression of two markers of kidney function. However, DAFP1 and TmAFP did not prevent the adverse effects of cold on kidneys over 72 h. Overall, DAFP1 is less toxic at high dose than TmAFP, and has potential for use in tissue preservation at doses up to 500 μg/mL. However, careful consideration must be taken due to the proinflammatory potential of DAFP1 on macrophages at higher doses and the heighten susceptibility of hepatocytes to both AFPs.
抗冻蛋白(AFPs)存在于许多适应寒冷的生物体中,可以保护它们免受寒冷和冰冻的伤害,因此被认为是当前低温组织保存溶液的额外保护剂,这些溶液通常包括电解质、渗透剂、胶体和抗氧化剂,以减少与低温保存相关的组织活力丧失。由于缺乏对 AFP 毒性特征的研究,它们在低温保存溶液中的加入一直是一个反复试验的过程,限制了 AFP 在低温保存中的应用发展。为了评估将 AFP 技术转化为哺乳动物细胞低温或冷冻保存的可行性,我们在这项研究中确定了两种来自加拿大白蜡树和黄粉虫的高活性甲虫 AFP(DAFP1 和 TmAFP)在哺乳动物细胞中的毒性特征。毒性在一组代表性的哺乳动物细胞系上进行了检测,包括睾丸精原干细胞和 Leydig 细胞、巨噬细胞和肝细胞。在三种细胞系中,DAFP1 和 TmAFP 的处理浓度高达 500μg/mL,处理时间为 48 和 72 h,是安全的,除了 TmAFP 处理的精原细胞活力下降 20%。然而,在 48 和 72 h 时,两种 AFP 在 500μg/mL 或以下浓度均使肝细胞活力降低 20-40%。在 1000μg/mL 时,DAFP1 和 TmAFP 降低了大多数细胞系的活力。虽然 1000μg/mL 的 DAFP1 对精原细胞和 Leydig 细胞功能没有影响,但这种处理会诱导巨噬细胞的炎症反应。将 1000μg/mL 的 DAFP1 添加到在 4°C 下保存 48 h 的大鼠肾脏中,根据组织形态和肾功能的两个标志物的基因和蛋白表达,保护组织免受与寒冷相关的损伤。然而,在 72 h 以上,DAFP1 和 TmAFP 不能防止寒冷对肾脏的不良影响。总的来说,在高剂量时,DAFP1 的毒性低于 TmAFP,并且在高达 500μg/mL 的剂量下具有用于组织保存的潜力。然而,由于 DAFP1 在较高剂量时对巨噬细胞的促炎潜力以及两种 AFP 对肝细胞的敏感性增加,因此必须谨慎考虑。